ARCHIVES

FDA Approves Gleevec For First Line Rx Of CML

This article is from The Cancer Letter archive.

Vol. 26 No. 1 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

Radiotherapy Provides Longer Life To Brain Cancer Patients

May 28, 2010

Levine, Mendelsohn Win Landon Awards; Ullrich Wins Pezcoller.

February 29, 2008

In Brief: Henderson Names to HHA Post; Nurses Support Cigarette Tax Increase; FDA Staff Changes

May 7, 1993

NCI Cooperative Groups Begin Trial Of Individualized Rx For Breast Cancer

May 26, 2006

In Brief: RFPs For Recompeting Frederick Contract Still Being Drafted; Panel Meets April 13

April 10, 1981

Organ Systems Program Adds Workshops On Lung, Colorectal Cancer

January 26, 1990